RecruitingNCT03207854

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

Protocol for Immunology Specimen Collection From Cancer Patients, Patients With Hematologic Diagnoses, and Healthy Normal Controls


Sponsor

University of Southern California

Enrollment

625 participants

Start Date

Apr 12, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

This research trial collects and stores blood, tissue, and bone marrow specimens from patients with cancer or blood disorders, and healthy volunteers to study the immune system in a variety of different types of experiments, as well as associated clinical data as appropriate, focused on understanding mechanisms of immunotherapy.


Eligibility

Min Age: 19 Years

Inclusion Criteria4

  • All patients known to have cancer, an immune-mediated hematologic diagnosis, or a healthy normal volunteer
  • Definition of immune-mediated hematologic diagnosis: diagnoses for which immune dysfunction and/or immune system directed therapy (eg. aplastic anemia, autoimmune hemolytic anemia, immune thrombocytopenic purpura \[ITP\], etc.) are involved
  • Definition of healthy normal volunteer: persons lacking diagnoses of any type of cancer, diabetes, cardiovascular diseases, non-hematologic autoimmune disease (eg. systemic lupus erythematosus \[SLE\], rheumatoid arthritis \[RA\], Crohn's disease) and not taking any immunosuppressive medications
  • Patients must have been seen in the Norris Hospital and outpatient clinics, or the Los Angeles County (LAC)-University of Southern California (USC) Medical Center or outpatient clinics; healthy volunteers can be recruited without any physician visit appointments since their labs are strictly for clinical research and not for personal health issues unrelated to the project

Exclusion Criteria4

  • Unable to give informed consent to specimen collection
  • Known human immunodeficiency virus (HIV) positive status
  • Persons taking any type of immunosuppressive medication are excluded from participating as healthy normal volunteers
  • Any patient for whom specimen collection is judged to be unsafe (for example, for patients unable to establish venous access)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBiospecimen Collection

Undergo collection of peripheral blood, bone marrow, and tissue

OTHERLaboratory Biomarker Analysis

Correlative studies

OTHERQuestionnaire Administration

Ancillary studies


Locations(1)

USC / Norris Comprehensive Cancer Center

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03207854


Related Trials